---
title: "Community-based mpox seroprevalence study in Manitoba and Alberta: evidence of undocumented exposu"
id: "medrxiv-17-community-based-assessment-of-mpox-seroprevalence-and-undocumented-exposures-in"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-17-community-based-assessment-of-mpox-seroprevalence-and-undocumented-exposures-in"
content_type: "clinical_feed_article"
specialty: "Infectious Disease"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.09.17.26363367v1?rss=1"
published_at: "2026-09-20T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Community-based mpox seroprevalence study in Manitoba and Alberta: evidence of undocumented exposu
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-17-community-based-assessment-of-mpox-seroprevalence-and-undocumented-exposures-in
- **Specialty:** [Infectious Disease](https://medichelpline.com/clinical-feed/infectious-disease.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.09.17.26363367v1?rss=1)
- **Published At:** 2026-09-20T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- A cross-sectional, community-based seroprevalence study was conducted among 275 individuals in Manitoba and Alberta to assess **mpox** exposure and undocumented infections during and after the 2022 global outbreak. - Participants were recruited between June 2024 and December 2025 and met provincial mpox vaccination eligibility criteria, which included but were not limited to **gbMSM**, gender-diverse individuals, and sex workers. - Dried blood spots were tested using the Meso Scale Discovery **Orthopoxvirus** assay targeting five orthologous mpox and vaccinia virus antigens to detect seroreactivity. - Self-reported mpox vaccination was 14.5% among participants. - Among participants who did not report prior Orthopoxvirus vaccination, 5.9% were seroreactive to multiple mpox antigens, indicating potential undetected mpox circulation in these provinces. - The seroreactive group included a broad range of gender identities and sexual orientations, suggesting misalignment between who was seroreactive and the vaccine eligibility criteria that focused primarily on men who have sex with men. - Authors interpret findings to support broader, non–gender- or sexuality-restricted mpox vaccine eligibility to better cover those at risk. - Ethical approvals were obtained from the University of Manitoba and the University of Alberta (committee identifiers reported). Data are available from the authors on reasonable request. - Funding was declared from the Canadian Institutes of Health Research and the International Development Research Centre. No competing interests were declared.
## Clinical Analysis & Structured Key Points
Community-based assessment of mpox seroprevalence and undocumented exposures in Manitoba and Alberta, Canada | medRxiv Skip to main content Community-based assessment of mpox seroprevalence and undocumented exposures in Manitoba and Alberta, Canada Elise Gork , View ORCID Profile Mikayla Hunter , View ORCID Profile Neve Battle , Nicole Wilson , Samantha Polege , Chelseay Robles , Venice Vincent , View ORCID Profile Garret Meyer , View ORCID Profile Hannah L Wallace , Lynora Saxinger , Jared Bullard , View ORCID Profile Megan L Halbrook , View ORCID Profile Sydney Merritt , View ORCID Profile Nicole A Hoff , Ryan S Noyce , View ORCID Profile Donald C Vinh , Rusty Souleymanov , View ORCID Profile Souradet Y Shaw , View ORCID Profile Placide Mbala-Kingebeni , View ORCID Profile Anne W Rimoin , View ORCID Profile Vanessa Meier-Stephenson , View ORCID Profile Jason Kindrachuk doi: https://doi.org/10.64898/2026.09.17.26363367 Elise Gork 1 University of Manitoba; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Mikayla Hunter 1 University of Manitoba; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Mikayla Hunter Neve Battle 2 University of Alberta; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Neve Battle Nicole Wilson 1 University of Manitoba; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Samantha Polege 2 University of Alberta; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Chelseay Robles 2 University of Alberta; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Venice Vincent 2 University of Alberta; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Garret Meyer 3 Alberta Health Services; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Garret Meyer Hannah L Wallace 1 University of Manitoba; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Hannah L Wallace Lynora Saxinger 2 University of Alberta; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Jared Bullard 1 University of Manitoba; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Megan L Halbrook 4 University of California Los Angeles Jonathan and Karin Fielding School of Public Health; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Megan L Halbrook Sydney Merritt 5 Jonathan and Karin Fielding School of Public Health, University of California, Los Angeles; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Sydney Merritt Nicole A Hoff 4 University of California Los Angeles Jonathan and Karin Fielding School of Public Health; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Nicole A Hoff Ryan S Noyce 2 University of Alberta; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Donald C Vinh 6 Research Institute of the McGill University Health Centre; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Donald C Vinh Rusty Souleymanov 1 University of Manitoba; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Souradet Y Shaw 1 University of Manitoba; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Souradet Y Shaw Placide Mbala-Kingebeni 7 INRB: Institut National de Recherche Biomedicale; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Placide Mbala-Kingebeni Anne W Rimoin 8 UCLA Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Anne W Rimoin Vanessa Meier-Stephenson 2 University of Alberta; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Vanessa Meier-Stephenson Jason Kindrachuk 1 University of Manitoba; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Jason Kindrachuk For correspondence: jason.kindrachuk{at}umanitoba.ca Abstract Info/History Metrics Data/Code Preview PDF Abstract During the 2022 global mpox outbreak, gay, bisexual and other men who have sex with men (gbMSM) were disproportionately affected,s however, the true number of cases is likely higher than reported due in part to the stigma associated with mpox. This stigma may have played an even more influential role on health-seeking behaviour in politically conservative regions, such as the Canadian Prairies. The shifting epidemiology may have also led to misdiagnoses during initial months of the outbreaks. Seroprevalence studies can help assess these gaps in surveillance and population-level immunity. To address this, we conducted a cross-sectional seroprevalence study among 275 individuals who identified as potentially eligible to receive the mpox vaccine in the Canadian provinces of Manitoba and Alberta from June 2024 to December 2025 based on provincial vaccination criteria. This eligibility included, but was not exclusively limited to, gbMSM, gender diverse individuals, and sex workers. Dried blood spots were analyzed using the Meso Scale Discovery Orthopoxvirus assay targeting five orthologous mpox and vaccinia virus antigens. In total, 14.5% of individuals self-reported receiving the mpox vaccine and of those without reported Orthopoxvirus vaccination, 5.9% were seroreactive to multiple mpox antigens. These results suggest the potential for undetected mpox circulation within Manitoba and Alberta. While primarily men who have sex with men were eligible for the mpox vaccine, an expansive range of gender and sexual orientation identities were classified as seroreactive, suggesting a misalignment between those who were seroreactive and vaccine eligibility criteria. This emphasizes how broader mpox vaccine eligibility, not restricted by specific gender and sexuality requirements, may better encompass those at risk of infection. Competing Interest Statement The authors have declared no competing interest. Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: Ethical approvals were obtained from both the Committee for Harmonized Health Impact, Privacy, and Ethics Review Health Research Ethics Board (IRB00012696) at the University of Manitoba, and the University of Alberta (Pro00146978), in accordance with university policies. All potential participants were made aware of the study rationale and potential harms prior to providing informed, written consent. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes Data Availability Data is available upon reasonable request to the authors. Funder Information Declared Canadian Institutes of Health Research, https://ror.org/01gavpb45 , MRR-184813 International Development Research Centre, https://ror.org/0445x0472 , MRR-184813 Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license . Back to top Previous Next Posted September 20, 2026. Download PDF Data/Code Email Thank you for your interest in spreading the word about medRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. You are going to email the following Community-based assessment of mpox seroprevalence and undocumented exposures in Manitoba and Alberta, Canada Message Subject (Your Name) has forwarded a page to you from medRxiv Message Body (Your Name) thought you would like to see this page from the medRxiv website. Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Share Community-based assessment of mpox seroprevalence and undocumented exposures in Manitoba and Alberta, Canada Elise Gork , Mikayla Hunter , Neve Battle , Nicole Wilson , Samantha Polege , Chelseay Robles , Venice Vincent , Garret Meyer , Hannah L Wallace , Lynora Saxinger , Jared Bullard , Megan L Halbrook , Sydney Merritt , Nicole A Hoff , Ryan S Noyce , Donald C Vinh , Rusty Souleymanov , Souradet Y Shaw , Placide Mbala-Kingebeni , Anne W Rimoin , Vanessa Meier-Stephenson , Jason Kindrachuk medRxiv 2026.09.17.26363367; doi: https://doi.org/10.64898/2026.09.17.26363367 Share This Article: Copy Citation Tools Community-based assessment of mpox seroprevalence and undocumented exposures in Manitoba and Alberta, Canada Elise Gork , Mikayla Hunter , Neve Battle , Nicole Wilson , Samantha Polege , Chelseay Robles , Venice Vincent , Garret Meyer , Hannah L Wallace , Lynora Saxinger , Jared Bullard , Megan L Halbrook , Sydney Merritt , Nicole A Hoff , Ryan S Noyce , Donald C Vinh , Rusty Souleymanov , Souradet Y Shaw , Placide Mbala-Kingebeni , Anne W Rimoin , Vanessa Meier-Stephenson , Jason Kindrachuk medRxiv 2026.09.17.26363367; doi: https://doi.org/10.64898/2026.09.17.26363367 Citation Manager Formats BibTeX Bookends EasyBib EndNote (tagged) EndNote 8 (xml) Medlars Mendeley Papers RefWorks Tagged Ref Manager RIS Zotero Tweet Widget Facebook Like Google Plus One Subject Area Infectious Diseases (except HIV/AIDS) Subject Areas All Articles Addiction Medicine (619) Allergy and Immunology (903) Anesthesia (334) Cardiovascular Medicine (4828) Dentistry and Oral Medicine (479) Dermatology (419) Emergency Medicine (651) Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1633) Epidemiology (15974) Forensic Medicine (33) Gastroenterology (1206) Genetic and Genomic Medicine (7065) Geriatric Medicine (734) Health Economics (1066) Health Informatics (5060) Health Policy (1437) Health Systems and Quality Improvement (1775) Hematology (587) HIV/AIDS (1347) Infectious Diseases (except HIV/AIDS) (16307) Intensive Care and Critical Care Medicine (1174) Medical Education (671) Medical Ethics (155) Nephrology (727) Neurology (7291) Nursing (368) Nutrition (1084) Obstetrics and Gynecology (1243) Occupational and Environmental Health (1005) Oncology (3614) Ophthalmology (1055) Orthopedics (398) Otolaryngology (457) Pain Medicine (472) Palliative Medicine (139) Pathology (709) Pediatrics (1805) Pharmacology and Therapeutics (739) Primary Care Research (768) Psychiatry and Clinical Psychology (5919) Public and Global Health (9770) Radiology and Imaging (2432) Rehabilitation Medicine and Physical Therapy (1456) Respiratory Medicine (1250) Rheumatology (642) Sexual and Reproductive Health (773) Sports Medicine (579) Surgery (782) Toxicology (107) Transplantation (305) Urology (293)
## Related Clinical Research

- [Understanding Parasitic Identification in Delusional Parasitosis](https://medichelpline.com/clinical-feed/plos-one-21-bridging-perception-and-reality-parasitic-identification-in-delusional.md)
- [Impact of mass oral cholera vaccination in Uvira, DRC: surveillance-based counterfactual analysis](https://medichelpline.com/clinical-feed/medrxiv-13-impact-of-mass-oral-cholera-vaccination-in-an-endemic-area-of-the-democratic.md)
- [Microbiome Profiling Identifies Prognostic Heterogeneity in Staphylococcus aureus Pneumonia](https://medichelpline.com/clinical-feed/medrxiv-18-microbiome-profiling-reveals-prognostic-heterogeneity-in-staphylococcus-aureus.md)
- [Kennedy renews attacks on vaccines at Children’s Health Defense conference](https://medichelpline.com/clinical-feed/stat-news-1-kennedy-renews-attacks-on-vaccines-at-children-s-health-defense-conference.md)
- [Study says purer fentanyl won’t by itself explain U.S. overdose death decline](https://medichelpline.com/clinical-feed/stat-news-2-purer-fentanyl-won-t-solve-the-u-s-overdose-death-crisis-study-says.md)

## Navigation
- [← Back to Infectious Disease Feed](https://medichelpline.com/clinical-feed/infectious-disease.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.